About the Fund
Investment Criteria
Contact Our Team
If you wish to apply for investment consideration, please complete this brief assessment and email the results and the pitch deck to Paul Nolde (paul@riverflow.vc).
Board Members
*Investment Committee
Portfolio Companies
DrugViu is generating the most comprehensive data for autoimmune research by combining medical records with validated patient-reported outcomes, a proprietary autoimmune biorepository and access to patients for clinical research.